These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 1322635

  • 1. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy.
    Kaneko A, Hayashi N, Tanaka Y, Ito T, Kasahara A, Kubo M, Mukuda T, Fusamoto H, Kamada T.
    Am J Gastroenterol; 1992 Aug; 87(8):1014-7. PubMed ID: 1322635
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
    Hioki O, Watanabe A, Minemura M, Tsuchida T.
    J Med; 1993 Aug; 24(1):35-46. PubMed ID: 7684768
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
    Higaki I, Yamazaki O, Matsuyama M, Horii K, Kawai S, Hirohashi K, Kinoshita H.
    Hepatogastroenterology; 1999 Aug; 46(26):1078-82. PubMed ID: 10370670
    [Abstract] [Full Text] [Related]

  • 6. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
    Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T.
    Hepatology; 1995 Jan; 21(1):106-12. PubMed ID: 7806142
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization.
    Yamazaki H, Nishimoto N, Oi H, Matsushita M, Ogata A, Shima Y, Inoue T, Tang JT, Yoshizaki K, Kishimoto T.
    Cytokine; 1995 Feb; 7(2):191-5. PubMed ID: 7780039
    [Abstract] [Full Text] [Related]

  • 9. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
    Takekoshi H, Oyama R.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
    [Abstract] [Full Text] [Related]

  • 10. Levels of human hepatocyte growth factor (hHGF) in peritoneal fluid after partial hepatectomy.
    Miyata K, Taniguchi H, Tsubouchi H, Daikuhara Y, Takahashi T.
    Hepatogastroenterology; 1996 Aug; 43(12):1594-600. PubMed ID: 8975971
    [Abstract] [Full Text] [Related]

  • 11. Significant increase in the antibody to Gal alpha 1-3Gal structure in sera of patients with hepatocellular carcinoma after transcatheter arterial embolization.
    Kashiwagi M, Ikeda Y, Iwamori M, Toda G, Nagai Y.
    Cancer Res; 1989 Aug 15; 49(16):4396-401. PubMed ID: 2545342
    [Abstract] [Full Text] [Related]

  • 12. [Changes in ketone body ratio and levels of pyruvate and lactate in arterial blood of patients with hepatocellular carcinoma after transcatheter arterial embolization].
    Mizobuchi N, Kuwao F, Takeda I, Takemura T, Morita S, Horimi T, Takahashi I.
    Rinsho Byori; 1990 Jul 15; 38(7):825-9. PubMed ID: 2169547
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum levels of transforming growth factor-alpha in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay.
    Tomiya T, Fujiwara K.
    Hepatology; 1993 Aug 15; 18(2):304-8. PubMed ID: 8340059
    [Abstract] [Full Text] [Related]

  • 17. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G, Umeki K, Okano J, Kawasaki H.
    J Med; 1995 Aug 15; 26(5-6):295-308. PubMed ID: 8721905
    [Abstract] [Full Text] [Related]

  • 18. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F, Wu L, Zheng S, Ding W, Teng L, Wang Z, Ma Z, Zhao W.
    Dig Liver Dis; 2006 Jul 15; 38(7):490-7. PubMed ID: 16627020
    [Abstract] [Full Text] [Related]

  • 19. Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepato-cellular carcinoma.
    Yamazaki H, Oi H, Matsumoto K, Matsushita M, Ozeki S, Teshima T, Murayama S, Inoue T, Nakamura T, Inoue T.
    Cytokine; 1996 Feb 15; 8(2):178-82. PubMed ID: 8777277
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of transcatheter arterial embolization in terms of serum alpha-fetoprotein doubling time in hepatocellular carcinoma].
    Kanno T, Harihara S, Kim K, Kimura S, Tamori A, Kuroki T, Mizoguchi Y, Kobayashi K, Monna T, Nakamura K.
    Gan To Kagaku Ryoho; 1988 Apr 15; 15(4 Pt 1):683-7. PubMed ID: 2451472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.